Pneumonia News

World Pneumonia Day is observed every year on Nov. 12 to raise awareness and promote interventions against pneumonia, which continues to be a global public health concern, according to a recent MMWR.

The FDA has granted Paratek Pharmaceuticals fast track designation for its investigational candidate omadacycline, which is currently in phase 3 development for the treatment of community-acquired pneumonia, complicated urinary tract infections and acute bacterial skin and skin structure infections, according to a press release.

Healio.com/Pulmonology will present live coverage from CHEST 2015 — the annual meeting of American College of Chest Physicians — that runs October 24-28 in Montreal, Canada.

SAN DIEGO — New information presented at IDWeek 2015 suggested that despite a high risk for infection, patients admitted to health care facilities with a primary diagnosis of pneumonia are infrequently tested for HIV.

Inflammatory bowel disease patients have an increased risk for invasive pneumococcal disease both before and after being diagnosed with either Crohn’s disease or ulcerative colitis, according to results from a Danish population-based cohort study.

Adults identified as current or former smokers demonstrated an increased risk for COPD and a greater likelihood of decreased lung function if they developed pneumonia as a child, according to study results.

Discretionary admittance to the ICU improved 30-day mortality and resulted in comparable Medicare spending in hospital costs among older patients with pneumonia, compared with patients admitted to general wards, according to data recently published in JAMA.

The FDA granted fast track designation to tipelukast for the treatment of patients with idiopathic pulmonary fibrosis, according to a press release from the drug’s manufacturer.

Commensal oropharyngeal flora appeared to be a possible cause of ventilator-associated pneumonia in a number of patients admitted to the ICU, according to study results.

A low maximal expiratory flow at 50% of forced vital capacity helped predict risks for respiratory symptoms in patients without spirometry-confirmed COPD, according to study results.